Researchers are a step closer to revolutionizing how doctors use radiotherapy to treat patients with muscle-invasive bladder cancer. A team of scientists, led by The Institute of Cancer Research, ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

A personalized strategy of dose-escalated radiotherapy (RT) for bladder cancer had a low rate of severe late toxicity and survival comparable to historical results with cystectomy, a randomized trial ...

Patients with nonmetastatic node-positive bladder cancer may have similar survival rates whether they underwent treatment with surgery or radical dose radiotherapy. Patients with nonmetastatic ...

Among patients undergoing radical cystectomy and perioperative chemotherapy for high-risk muscle-invasive bladder cancer (MIBC), adjuvant radiotherapy cut locoregional recurrence risk by more than ...

Whole pelvis radiation improves cancer-specific and overall survival in muscle-invasive bladder cancer compared to bladder-only radiation. Median cancer-specific survival was 84 months for whole ...

Second-line platinum-based chemotherapy (PBT) in patients with metastatic urothelial carcinoma (mUC) treated with first-line pembrolizumab plus enfortumab vedotin (P/EV): A single-center, ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced muscle-invasive bladder cancer had lower risk for local recurrence with adjuvant ...

New Delhi: Post-surgery radiation therapy significantly reduces risk of recurrence in patients with high-risk muscle-invasive bladder cancer (MIBC), following a surgical removal of the organ and ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...